CClinicalTrials.gg
CompletedNCT05441241LeapRCTUpdated Sep 7, 2023

Leap Motion Controller for Pain During Venipuncture in Pediatrics

An interventional study of Leap Motion Controller and Traditional distraction techniques in Procedural Pain and Venipuncture, sponsored by IRCCS Burlo Garofolo. Completed at 1 site in Italy. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2023-09-07.

Sponsored by IRCCS Burlo Garofolo · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
8 Years to 17 Years
Sex
All
01

Study summary

Venipuncture is the most frequent invasive procedure in hospitals and clinics. In the pediatric population this is very often associated with fear, anxiety, distress and enhanced perception of pain. Local anesthetic creams (like EMLA) are used to reduce pain and distress but they need 30-60 minutes of waiting between the application and the puncture, which is too much time for most of everyday life clinical contests. Many distraction techniques have been studied, both active (ie video games, virtual reality) and passive (ie listening to music, visual stimulation).

Active production of music is one of the most complex activities for our central nervous system. It requires a precise timing of a lot of well-coordinated actions, like recognition and conservation of a rhythmic structure, precise execution of quick and complex fine movements, and with an important involvement of intense emotional experience. It stimulates bilaterally primary and secondary auditory cerebral areas, but also motor and premotor areas, language areas and their contralateral, cognitive areas. At the same time, it activates reward and gratification circuits with stimulation of the limbic system and endorphin release and also neurovegetative system. Music is probably the most immediate and spontaneous communication tool that can also act at subcortical level without the person being aware of what they are receiving and transmitting. Music activates the dopaminergic mesolimbic system, which regulates memory, attention, executive functions, motivation and also mood and pleasure through the nucleus accumbens. It also produces measurable cardiovascular and endocrine responses indicated by reduced serum cortisol levels and inhibition of cardiovascular stress reactions.

The Leap Motion Controller is an infrared device that digitalizes the movements of the hand above it in real-time: this is connected with a software that converts this signal into a musical tone specifically set. The melody is created very easily just by moving the hand above it. With this device, children will be able to produce music without anything interposing between them and the sound production. This will allow the patient to focus only on the melodies, without technical difficulties that could derive for instance from a visual interface or an instrument you have to hold.

02

Conditions studied

  • Procedural Pain
  • Venipuncture

Browse trials for

Keywords

  • Procedural Pain
  • Venipuncture
  • Children, Distraction
03

In context

Pain, Procedural

237 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

This study's enrollment of 300 is above the median of 83 across 223 interventional studies indexed under Pain, Procedural.

Browse Pain, Procedural studies →

Lead sponsor

IRCCS Burlo Garofolo is the lead sponsor of 87 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children aged 8-17 years undergoing venipuncture

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive impairment
  • Patients who do not understand the Italian language or with parents who are unable to provide a written informed consent in Italian language
  • Patients medicated with local anaesthetic cream
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (actual)

Study arms

  • Experimental
    Leap Motion Controller

    Device: Leap Motion Controller

  • Active comparator
    Standard care

    Other: Traditional distraction techniques

Interventions

  • DeviceLeap Motion Controller

    The Leap Motion Controller is an infrared device that digitalizes in real-time the movements of the hand above it. This signal will be converted into Musical Instrument Digital Interface (MIDI) and then translated into a sound of a pitch that depends on the distance between the hand and the device. The software is set to produce a pentatonic scale, so every melody created by the patient will sound consonant, and the timbre will be warm, calm and in human vocal range (similar to a cello). The operator will do an example, playing a melody, and will invite the patient to imitate him. When the patient gains confidence with the device, after a limited time lapse (from 30 seconds to 3 minutes), while they are playing it with one hand, the venipuncture is done on the other arm

  • OtherTraditional distraction techniques

    Common distraction techniques will be used (i.e., visual stimulation, lecture)

06

What researchers measure

Primary outcomes

  1. Difference in procedural pain score between experimental and control group

    Procedural pain self-reported by children using the Faces Pain Scale Revised (FPS-R scale). The FPS-R algometric scale includes both a series of smiley faces with an expression that changes according to increasing pain, and a numerical scale, for a pain scale ranging from zero (no pain) to 10 (severe pain).

    Time frame: 1 minutes after the procedure

Secondary outcomes

  1. Difference in child distress between experimental and control group evaluated by parents

    The distress score will be evaluated by parents through the Distress thermometer, a single-item tool using a 0 (no distress) to 10 (extreme distress)-point Likert scale resembling a thermometer.

    Time frame: 1 minutes before the procedure

  2. Difference in child distress between experimental and control group evaluated by health operators

    The distress score will be evaluated by health operators through the Distress thermometer, a single-item tool using a 0 (no distress) to 10 (extreme distress)-point Likert scale resembling a thermometer.

    Time frame: 1 minutes before the procedure

07

Study locations

1 site
  • Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
    Trieste, 34137, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05441241
Lead sponsor
IRCCS Burlo Garofolo
Responsible party
Sponsor
First posted
Jul 1, 2022
Start date
Jul 1, 2022
Primary completion
Oct 30, 2022
Completion
Oct 30, 2022
Last update
Sep 7, 2023

Study contacts

Egidio Barbi, MD
principal investigator · Institute for Maternal and Child Health IRCCS Burlo Garofolo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion